卷曲霉素(capreomycin)属多肽类抗生素,其抗菌作用机制是阻碍结核菌细胞内蛋白的合成。国内70年代开始研制。1985年我厂采用成都生物研究所抗噬菌体菌种试制,1986年批量生产,目前20多个省市用其治疗肺结核。卷曲霉素问世时间不长,就受到 Capreomycin (capreomycin) is a peptide antibiotic, the antibacterial mechanism is to inhibit tuberculosis cell protein synthesis. Domestic 70 years began to develop. In 1985, our factory used the trial of anti-bacteriophage strains of Chengdu Institute of Biology. In 1986, it was mass-produced. At present, more than 20 provinces and cities use it to treat tuberculosis. Caprizomycin come out of time is not long, it is received